Increased expression of CXCL16, a bacterial scavenger receptor, in the colon of children with ulcerative colitis.
暂无分享,去创建一个
[1] S. Geller,et al. Crohn disease , 2015, Autopsy & case reports.
[2] R. Puri,et al. IL-13Rα2-bearing, type II NKT cells reactive to sulfatide self-antigen populate the mucosa of ulcerative colitis , 2014, Gut.
[3] Dan Knights,et al. Advances in inflammatory bowel disease pathogenesis: linking host genetics and the microbiome , 2013, Gut.
[4] S. Melgar,et al. Pattern recognition receptors--molecular orchestrators of inflammation in inflammatory bowel disease. , 2013, Cytokine & growth factor reviews.
[5] W. Sandborn,et al. Crohn's disease , 2012, The Lancet.
[6] S. Cox,et al. Microbiota Separation and C-reactive Protein Elevation in Treatment-naïve Pediatric Granulomatous Crohn Disease , 2012, Journal of pediatric gastroenterology and nutrition.
[7] R. Satokari,et al. Expression of Microbiota, Toll-like Receptors, and Their Regulators in the Small Intestinal Mucosa in Celiac Disease , 2012, Journal of pediatric gastroenterology and nutrition.
[8] R. Siebert,et al. Microbial Exposure During Early Life Has Persistent Effects on Natural Killer T Cell Function , 2012, Science.
[9] 宇座 徳光. SR-PSOX/CXCL16 plays a critical role in the progression of colonic inflammation , 2011 .
[10] S. Brand,et al. Expression and regulation of the chemokine CXCL16 in Crohn's disease and models of intestinal inflammation , 2010, Inflammatory bowel diseases.
[11] B. Müller-Myhsok,et al. Genotype-phenotype analysis of the CXCL16 p.Ala181Val polymorphism in inflammatory bowel disease. , 2008, Clinical immunology.
[12] F. Seibold,et al. CXCL16 is a surrogate marker of inflammatory bowel disease , 2008, Scandinavian journal of gastroenterology.
[13] R. Baldassano,et al. Lamina Propria and Circulating Interleukin-8 in Newly and Previously Diagnosed Pediatric Inflammatory Bowel Disease Patients , 2007, Digestive Diseases and Sciences.
[14] R. Macdermott. Chemokines in the Inflammatory Bowel Diseases , 1999, Journal of Clinical Immunology.
[15] T. Kita,et al. Cutting Edge: SR-PSOX/CXC Chemokine Ligand 16 Mediates Bacterial Phagocytosis by APCs Through its Chemokine Domain1 , 2003, The Journal of Immunology.
[16] G. Rogler,et al. Human intestinal epithelial cells secrete interleukin-1 receptor antagonist and interleukin-8 but not interleukin-1 or interleukin-6 , 2000, Gut.
[17] R. Macdermott,et al. Increased interleukin-8 (IL-8) in rectal dialysate from patients with ulcerative colitis: evidence for a biological role for IL-8 in inflammation of the colon. , 1999 .
[18] R. Macdermott,et al. Increased interleukin-8 (IL-8) in rectal dialysate from patients with ulcerative colitis: evidence for a biological role for IL-8 in inflammation of the colon , 1999, American Journal of Gastroenterology.
[19] L. Mazzucchelli,et al. Expression of interleukin-8 gene in inflammatory bowel disease is related to the histological grade of active inflammation. , 1994, The American journal of pathology.
[20] W. Tremaine,et al. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. , 1987, The New England journal of medicine.
[21] G PLACITELLI,et al. [Ulcerative colitis]. , 1958, La Riforma medica.
[22] C. FordAlexander,et al. ULCERATIVE colitis. , 1997, Journal of the American Medical Association.